Merck inks $2.13B deal for experimental cancer drugBy jay.trebleOctober 2, 2026 The basics: Merck will pay up to $2.13B for global rights to SPR2015 SciBrunch will receive $400M upfront, up to $1.73B in milestones SPR2015 targets cancer-driving…
3
4
5
